LexDanaLexDanabeta
Inventor

David Paul Humphreys

Inventor
Slough, GB

Overview

38→
Patents
2003–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 38 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C12NMicroorganisms or enzymes16%
A61KPreparations for medical, dental or toiletry purposes8%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture6%
Y02PClimate change mitigation technologies in the production or processing of goods5%
C12YEnzymes4%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms3%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds1%
C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients1%
PatentTitleYear
11,091,542Antibody molecules which bind TNF alpha202111,059,911Sequence symmetric modified IgG4 bispecific antibodies202110,759,844Disulfide stabilised antibodies and fragments thereof202010,752,676Neutralising antibodies to the major exotoxins TCDA and TCDB of 202010,562,966Antibodies of the class IGG4202010,472,426Disulfide stabilized DVD-Ig molecules201910,457,748Single linker FabFv antibodies and methods of producing same201910,421,816Multivalent antibodies201910,221,251Sequence symmetric modified IGG4 bispecific antibodies201910,100,130Dual specificity antibody fusions201810,023,631Albumin binding antibodies and binding fragments thereof20189,957,328Bacterial host strain expressing recombinant DSBC20189,951,365Recombinant bacterial host cell for protein expression20189,902,768'Sequence asymmetric modified IgG4 bispecific antibodies'20189,873,735Method of treatment with antibodies having specificity for human OX4020189,828,438Dual specificity antibody fusions20179,803,004'Albumin binding antibodies and binding fragments thereof'20179,725,516'Bacterial host strain expressing recombinant DSBC'20179,587,227'Bacterial host strain comprising a mutant spr gene and having reduced Tsp activity'20179,550,973'Bacterial host strain'20179,493,558'Bacterial host strain comprising a mutant SPR gene and a wild-type TSP gene'20169,493,559'Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity'20169,315,770'Bacterial host strain'20169,309,327'Dual specificity antibody fusions'20169,109,216'Bacterial host strain'20159,045,529'Disulfide stabilized antibodies and fragments thereof'20159,040,048'Antibody molecules having specificity for human OX40'20158,969,037'Bacterial host strain comprising a mutant spr gene and a wild-type Tsp gene'20158,969,039'Bacterial host strain comprising a mutant SPR gene and having reduced TSP activity'20158,969,038'Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity'20158,629,246'Dual specificity antibody fusions'20148,507,654'Altered antibodies'20138,062,865'Expression control using antibody expression optimisation sequences'20118,053,562'Modified antibody fragments'20117,989,594'Modified antibody fab fragments'20117,662,609'E.coli host cells with modified PhoS/PstS periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs'20107,244,587'Expression vectors encoding bacteriophage signal peptides'20076,642,356'Peptides which function as hinge regions in protein'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2011Based in Maidenhead, GB· patent location history
2010–2020Patents assigned to UCB PHARMA SA (26)· patent assignee history
2011–2020Patents assigned to HUMPHREYS DAVID PAUL (12)· patent assignee history
2011–2017Patents assigned to ELLIS MARK (6)· patent assignee history
2011–2021Based in Slough, GB· patent location history
2014–2019Patents assigned to HEYWOOD SAM PHILIP (2)· patent assignee history
2015–2021Patents assigned to UCB BIOPHARMA SPRL (14)· patent assignee history
2019–2020Based in Berkshire, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UCB PHARMA SA262010–2020
UCB BIOPHARMA SPRL142015–2021
HUMPHREYS DAVID PAULself122011–2020
ELLIS MARK62011–2017
HEYWOOD SAM PHILIP22014–2019
Locations
LocationPatentsSpan
Slough, GB312011–2021
Maidenhead, GB42003–2011
Berkshire, GB32019–2020